John Egan

Part of Surmodics, Inc., Vetex Medical Ltd. is a medical company based in Galway, Ireland. The Irish company's first innovation is the Revene thrombectomy catheter, which is specifically engineered for the treatment of venous disease. The catheter is 510(k) cleared by the FDA for mechanical de-clotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature. The company was founded by Mark Bruzzi, who has been the CEO since incorporation. Vetex Medical was acquired by SurModics MD LLC on July 06, 2021 for $59.78 million.

Part of Surmodics, Inc., Vetex Medical Ltd. is a medical company based in Galway, Ireland. The Irish company's first innovation is the Revene thrombectomy catheter, which is specifically engineered for the treatment of venous disease. The catheter is 510(k) cleared by the FDA for mechanical de-clotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature. The company was founded by Mark Bruzzi, who has been the CEO since incorporation. Vetex Medical was acquired by SurModics MD LLC on July 06, 2021 for $59.78 million.

Part of Surmodics, Inc., Vetex Medical Ltd. is a medical company based in Galway, Ireland. The Irish company's first innovation is the Revene thrombectomy catheter, which is specifically engineered for the treatment of venous disease. The catheter is 510(k) cleared by the FDA for mechanical de-clotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature. The company was founded by Mark Bruzzi, who has been the CEO since incorporation. Vetex Medical was acquired by SurModics MD LLC on July 06, 2021 for $59.78 million.